BioCentury
ARTICLE | Company News

AltaRex Corp., United Therapeutics deal

August 18, 2003 7:00 AM UTC

The companies expanded an April deal under which UTHR received an exclusive license from AXO to develop and commercialize five antibodies to treat various cancers (see BioCentury, April 22). As expand...